# Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom

> **NCT01012245** · — · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 28812 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT01012245
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 28812 (ACTUAL)
- **Last updated:** 2021-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01012245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01012245, "Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01012245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*